Renoprotective Roles of Curcumin.
Apoptosis
Chronic kidney disease
Curcumin
Diabetic nephropathy
Inflammation
Oxidative stress
Journal
Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
4
1
2022
pubmed:
5
1
2022
medline:
6
1
2022
Statut:
ppublish
Résumé
The use of herb-based therapies is increasing over the past decades. These agents have been reported to provide many beneficial effects in many experimental and clinical studies. Curcumin is one of these agents which has potent pharmacological effects enabling it for the prevent and treatment of many diseases and pathologies such as renal disorders, hyperglycemia, oxidative stress, hypertension, and dyslipidemia. However, the exact molecular mechanisms mediating these renoprotective effects of curcumin are not well established. So, in the current study, we surveyed for possible renoprotective roles of curcumin and concluded how curcumin protects against renal injuries.
Identifiants
pubmed: 34981504
doi: 10.1007/978-3-030-73234-9_38
doi:
Substances chimiques
Antioxidants
0
Curcumin
IT942ZTH98
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
531-544Informations de copyright
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Références
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., et al. (2013). Chronic kidney disease: Global dimension and perspectives. The Lancet, 382(9888), 260–272.
Coca, S. G., Singanamala, S., & Parikh, C. R. (2012). Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney International, 81(5), 442–448.
pubmed: 22113526
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018). The global epidemiology of diabetes and kidney disease. Advances in Chronic Kidney Disease, 25(2), 121–132.
pubmed: 29580576
Zghebi, S. S., Steinke, D. T., Carr, M. J., Rutter, M. K., Emsley, R. A., & Ashcroft, D. M. (2017). Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes, Obesity and Metabolism, 19(11), 1537–1545.
pubmed: 28387052
Galaviz, K. I., Weber, M. B., Straus, A., Haw, J. S., Narayan, K. V., & Ali, M. K. (2018). Global diabetes prevention interventions: A systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care, 41(7), 1526–1534.
pubmed: 29934481
pmcid: 6463613
Beckman, J. A., & Creager, M. A. (2016). Vascular complications of diabetes. Circulation Research, 118(11), 1771–1785.
pubmed: 27230641
Gomez-Lopera, N., Pineda-Trujillo, N., & Diaz-Valencia, P. A. (2019). Correlating the global increase in type 1 diabetes incidence across age groups with national economic prosperity: A systematic review. World Journal of Diabetes, 10(12), 560.
pubmed: 31915518
pmcid: 6944530
Yaribeygi, H., Atkin, S. L., Simental-Mendía, L. E., Barreto, G. E., & Sahebkar, A. (2019). Anti-inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways. Journal of Cellular Physiology, 234(9), 14873–14882.
Yaribeygi, H., Maleki, M., Sathyapalani, T., & Sahebkar, A. (2019). The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms. Life Sciences, 237, 116950.
Yaribeygi, H., Butler, A. E., & Sahebkar, A. (2019). Aerobic exercise can modulate the underlying mechanisms involved in the development of diabetic complications. Journal of Cellular Physiology, 234(8), 12508–12515.
pubmed: 30623433
Warren, A. M., Knudsen, S. T., & Cooper, M. E. (2019). Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opinion on Therapeutic Targets, 23(7), 579–591.
pubmed: 31154867
Hatcher, H., Planalp, R., Cho, J., Torti, F., & Torti, S. (2008). Curcumin: From ancient medicine to current clinical trials. Cellular and Molecular Life Sciences, 65(11), 1631–1652.
pubmed: 18324353
Ghandadi, M., & Sahebkar, A. (2017). Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 23(6), 921–931.
pubmed: 27719643
Mollazadeh, H., Cicero, A. F. G., Blesso, C. N., Pirro, M., Majeed, M., & Sahebkar, A. (2019). Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition, 59(1), 89–101.
pubmed: 28799796
Momtazi, A. A., Derosa, G., Maffioli, P., Banach, M., & Sahebkar, A. (2016). Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Molecular Diagnosis and Therapy, 20(4), 335–345.
pubmed: 27241179
Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T. P., & Sahebkar, A. (2018). Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Journal of Cellular Physiology, 233(1), 141–152.
pubmed: 28012169
Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mendía, L. E., Majeed, M., et al. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled trial. Drug Research, 68(7), 403–409.
pubmed: 29458218
Sadeghian, M., Rahmani, S., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A. (2021). The effect of oral curcumin supplementation on health-related quality of life: A systematic review and meta-analysis of randomized controlled trials. Journal of Affective Disorders, 278, 627–636.
Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mendía, L.E., Majeed, M., Sahebkar, A. (2018) Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes Mellitus: a randomized double-blind placebo-controlled trial. Drug Research, 68(7), 403-409.
Teymouri, M., Pirro, M., Johnston, T. P., & Sahebkar, A. (2017). Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. Bio Factors, 43(3), 331–346.
Soetikno, V., Watanabe, K., Sari, F. R., Harima, M., Thandavarayan, R. A., Veeraveedu, P. T., et al. (2011). Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. Molecular Nutrition & Food Research, 55(11), 1655–1665.
Lu, M., Yin, N., Liu, W., Cui, X., Chen, S., & Wang, E. (2017). Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling. BioMed Research International, 2017, 1516985.
Ameh, O. I., Okpechi, I. G., Agyemang, C., & Kengne, A. P. (2019). Global, regional, and ethnic differences in diabetic nephropathy. In Diabetic Nephropathy (pp. 33–44). Springer.
Metsärinne, K., Bröijersen, A., Kantola, I., Niskanen, L., Rissanen, A., Appelroth, T., et al. (2015). High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care. Primary Care Diabetes, 9(1), 31–38.
pubmed: 25066820
Aldukhayel, A. (2017). Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries. International Journal of Health Sciences, 11(1), 1.
pubmed: 28293155
pmcid: 5327670
Yaribeygi, H., Farrokhi, F. R., Rezaee, R., & Sahebkar, A. (2018). Oxidative stress induces renal failure: A review of possible molecular pathways. Journal of Cellular Biochemistry, 119(4), 2990–2998.
pubmed: 29111576
Yaribeygi, H., Katsiki, N., Butler, A. E., & Sahebkar, A. (2019). Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys. Drug Discovery Today, 24(1), 256–262.
Yaribeygi, H., Atkin, S. L., Pirro, M., & Sahebkar, A. (2019). A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. Journal of Cellular Physiology, 234(6), 8286–8294.
pubmed: 30417367
Arora, M. K., & Singh, U. K. (2013). Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update. Vascular Pharmacology, 58(4), 259–271.
pubmed: 23313806
Roelofs, J. J., & Vogt, L. (2018). Diabetic nephropathy: Pathophysiology and clinical aspects. Springer.
Kita, T., Imai, S., Sawada, H., Kumagai, H., & Seto, H. (2008). The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors. Bioscience, Biotechnology, and Biochemistry, 72(7), 1789–1798.
pubmed: 18603793
Trujillo, J., Chirino, Y. I., Molina-Jijón, E., Andérica-Romero, A. C., Tapia, E., & Pedraza-Chaverrí, J. (2013). Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biology, 1(1), 448–456.
pubmed: 24191240
pmcid: 3814973
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017). The essential medicinal chemistry of curcumin: Miniperspective. Journal of Medicinal Chemistry, 60(5), 1620–1637.
pubmed: 28074653
pmcid: 5346970
Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., et al. (2017). Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. British Journal of Pharmacology, 174(11), 1325–1348.
pubmed: 27638428
Abdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018). Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Journal of Cellular Physiology, 233(2), 830–848.
pubmed: 28059453
Fan, Y., Chen, H., Peng, H., Huang, F., Zhong, J., & Zhou, J. (2017). Molecular mechanisms of curcumin renoprotection in experimental acute renal injury. Frontiers in Pharmacology, 8, 912.
Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2010). β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids and Surfaces B: Biointerfaces, 79(1), 113–125.
pubmed: 20456930
Lababidi, N., Sigal, V., Koenneke, A., Schwarzkopf, K., Manz, A., & Schneider, M. (2019). Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration. Beilstein Journal of Nanotechnology, 10(1), 2280–2293.
pubmed: 31807413
pmcid: 6880834
Lopresti, A. L., & Drummond, P. D. (2017). Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. Journal of Affective Disorders, 207, 188–196.
Teter, B., Morihara, T., Lim, G., Chu, T., Jones, M., Zuo, X., et al. (2019). Curcumin restores innate immune Alzheimer’s disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiology of Disease, 127, 432–448.
Hussain, Z., Thu, H. E., Amjad, M. W., Hussain, F., Ahmed, T. A., & Khan, S. (2017). Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: A review of new trends and future perspectives. Materials Science and Engineering: C, 77, 1316–1326.
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., et al. (2005). Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nature Medicine, 11(8), 867–874.
pubmed: 16041383
Cheung, A., Chertow, G., Greene, T., Kimmel, P., Rahman, M., Reboussin, D., et al. (2018). Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease. Journal of Internal Medicine, 284, 106–107.
Russell, V. (2017). Is the use of the Chinese herbal medicine, ningdong granule, a safe and effective alternative to haloperidol for the treatment of tic symptoms in pediatric patients with Tourette Syndrome (TS)? Available at: https://digitalcommons.pcom.edu/cgi/viewcontent.cgi?article=1420&context=pa_systematic_reviews#:~:text=Last%2C%20all%20studies%20used%20only,tics%20in%20the%20patient%20population.&text=Ningdong%20granule%20is%20a%20safe,patients%20diagnosed%20with%20Tourette%20Syndrome .
McLean, W. (2018). Green tea as a safe treatment for non-alcoholic fatty liver disease. Australian Journal of Herbal and Naturopathic Medicine, 30(4), 192–194.
Shoskes, D. A. (1998). Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: A new class of renoprotective agents 1. Transplantation, 66(2), 147–152.
pubmed: 9701255
Ugur, S., Ulu, R., Dogukan, A., Gurel, A., Yigit, I. P., Gozel, N., et al. (2015). The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Renal Failure, 37(2), 332–336.
pubmed: 25594614
Sies, H., Berndt, C., & Jones, D. P. (2017). Oxidative stress. Annual Review of Biochemistry, 86715–86748.
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., et al. (2018). Oxidative stress, aging, and diseases. Clinical Interventions in Aging, 13, 757–772.
Gyurászová, M., Kovalčíková, A. G., Renczés, E., Kmeťová, K., Celec, P., Bábíčková, J., et al. (2019). Oxidative stress in animal models of acute and chronic renal failure. Disease Markers, 2019, 8690805.
Kowluru, R. A., & Kanwar, M. (2007). Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition & Metabolism, 4(1), 8.
Fu, Y., Zheng, S., Lin, J., Ryerse, J., & Chen, A. (2008). Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Molecular Pharmacology, 73(2), 399–409.
pubmed: 18006644
Scapagnini, G., Colombrita, C., Amadio, M., D'Agata, V., Arcelli, E., Sapienza, M., et al. (2006). Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxidants & Redox Signaling, 8(3–4), 395–403.
Chico, L., Ienco, E. C., Bisordi, C., Lo Gerfo, A., Petrozzi, L., Petrucci, A., et al. (2018). Amyotrophic Lateral Sclerosis and oxidative stress: A double-blind therapeutic trial after curcumin supplementation. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 17(10), 767–779.
Al-Kuraishy, H. M., Al-Gareeb, A., & Rasheed, H. A. (2019). Antioxidant and anti-inflammatory effects of curcumin contribute into attenuation of acute gentamicin-induced nephrotoxicity in rats. Asian Journal of Pharmaceutical and Clinical Research, 12(3), 466–468.
Fazal, Y., Fatima, S. N., Shahid, S. M., & Mahboob, T. (2015). Effects of curcumin on angiotensin-converting enzyme gene expression, oxidative stress and anti-oxidant status in thioacetamide-induced hepatotoxicity. Journal of the Renin-Angiotensin-Aldosterone System, 16(4), 1046–1051.
pubmed: 25143335
Li, H.-Y., Yang, M., Li, Z., & Meng, Z. (2017). Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress. International Journal of Molecular Medicine, 39(5), 1307–1316.
pubmed: 28339005
Momeni, H. R., & Eskandari, N. (2017). Effect of curcumin on kidney histopathological changes, lipid peroxidation and total antioxidant capacity of serum in sodium arsenite-treated mice. Experimental and Toxicologic Pathology, 69(2), 93–97.
pubmed: 27908582
Ali, B. H., Al-Salam, S., Al Suleimani, Y., Al Kalbani, J., Al Bahlani, S., Ashique, M., et al. (2018). Curcumin ameliorates kidney function and oxidative stress in experimental chronic kidney disease. Basic & Clinical Pharmacology & Toxicology, 122(1), 65–73.
Yang, Y., Duan, W., Lin, Y., Yi, W., Liang, Z., Yan, J., et al. (2013). SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radical Biology and Medicine, 65, 667–679.
Mora, C., & Navarro, J. F. (2006). Inflammation and diabetic nephropathy. Current Diabetes Reports, 6(6), 463–468.
pubmed: 17118230
Mahmood, N., Rashid Awan, M. S., Akhlaq, H., & Amir, S. (2018). Correlation of inflammatory markers C-reactive protein and interleukin 6 with visfatin in chronic kidney disease patients. Clinical Trials and Drug Interactions, 1(1), 29–35.
Kooman, J. P., Dekker, M. J., Usvyat, L. A., Kotanko, P., van der Sande, F. M., Schalkwijk, C. G., et al. (2017). Inflammation and premature aging in advanced chronic kidney disease. American Journal of Physiology-Renal Physiology, 313(4), F938–F950.
pubmed: 28701312
Navarro-González, J. F., Mora-Fernández, C., De Fuentes, M. M., & García-Pérez, J. (2011). Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology, 7(6), 327.
pubmed: 21537349
Wada, J., & Makino, H. (2013). Inflammation and the pathogenesis of diabetic nephropathy. Clinical Science, 124(3), 139–152.
pubmed: 23075333
Elmarakby, A. A., & Sullivan, J. C. (2012). Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular Therapeutics, 30(1), 49–59.
pubmed: 20718759
Ghosh, S. S., Krieg, R., Massey, H. D., Sica, D. A., Fakhry, I., Ghosh, S., et al. (2012). Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5∕6 nephrectomized rats: Role of phospholipase and cyclooxygenase. American Journal of Physiology-Renal Physiology, 302(4), F439–F454.
pubmed: 22031851
Awad, A. S., & El-Sharif, A. A. (2011). Curcumin immune-mediated and anti-apoptotic mechanisms protect against renal ischemia/reperfusion and distant organ induced injuries. International Immunopharmacology, 11(8), 992–996.
pubmed: 21354353
Soetikno, V., Sari, F. R., Lakshmanan, A. P., Arumugam, S., Harima, M., Suzuki, K., et al. (2013). Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the N rf 2–keap1 pathway. Molecular Nutrition & Food Research, 57(9), 1649–1659.
Buyuklu, M., Kandemir, F. M., Ozkaraca, M., Set, T., Bakirci, E. M., & Topal, E. (2014). Protective effect of curcumin against contrast induced nephropathy in rat kidney: What is happening to oxidative stress, inflammation, autophagy and apoptosis. European Review for Medical and Pharmacological Sciences, 18(4), 461–470.
pubmed: 24610611
Reed, J. C. (2000). Mechanisms of apoptosis. The American Journal of Pathology, 157(5), 1415–1430.
pubmed: 11073801
pmcid: 1885741
Sanz, A. B., Santamaría, B., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2008). Mechanisms of renal apoptosis in health and disease. Journal of the American Society of Nephrology, 19(9), 1634–1642.
pubmed: 18632846
Nagata, S. (2018). Apoptosis and clearance of apoptotic cells. Annual Review of Immunology, 36, 489–517.
Mehta, N., Gava, A. L., Zhang, D., Gao, B., & Krepinsky, J. C. (2019). Follistatin protects against glomerular mesangial cell apoptosis and oxidative stress to ameliorate chronic kidney disease. Antioxidants & Redox Signaling, 31(8), 551–571.
Coughlan, M. T., Higgins, G. C., Nguyen, T.-V., Penfold, S. A., Thallas-Bonke, V., Tan, S. M., et al. (2016). Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis. Diabetes, 65(4), 1085–1098.
pubmed: 26822084
Schelling, J. R. (2016). Tubular atrophy in the pathogenesis of chronic kidney disease progression. Pediatric Nephrology, 31(5), 693–706.
pubmed: 26208584
Mortezaee, K., Salehi, E., Mirtavoos-mahyari, H., Motevaseli, E., Najafi, M., Farhood, B., et al. (2019). Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy. Journal of Cellular Physiology, 234(8), 12537–12550.
pubmed: 30623450
Wei, Y., Gao, J., Qin, L., Xu, Y., Shi, H., Qu, L., et al. (2017). Curcumin suppresses AGEs induced apoptosis in tubular epithelial cells via protective autophagy. Experimental and Therapeutic Medicine, 14(6), 6052–6058.
pubmed: 29285156
pmcid: 5740722
Wu, J., Pan, X., Fu, H., Zheng, Y., Dai, Y., Yin, Y., et al. (2017). Effect of curcumin on glycerol-induced acute kidney injury in rats. Scientific Reports, 7(1), 1–11.
Alkuraishy, H. M., Al-Gareeb, A. I., & Rasheed, H. A. (2019). Nephroprotective effect of Curcumin (Curcuma Longa) in acute nephrotoxicity in Sprague-Dawley rats. Journal of Contemporary Medical Sciences, 5(2). Retrieved from http://www.jocms.org/index.php/jcms/article/view/580
Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., et al. (2017). Angiotensin II for the treatment of vasodilatory shock. New England Journal of Medicine, 377(5), 419–430.
pubmed: 28528561
Fountain, J. H., & Lappin, S. L. (2019). Physiology, Renin Angiotensin System. In StatPearls [Internet]. StatPearls Publishing.
Okuyama, S., Sakagawa, T., Chaki, S., Imagawa, Y., Ichiki, T., & Inagami, T. (1999). Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Research, 821(1), 150–159.
pubmed: 10064799
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000). A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry, 275(43), 33238–33243.
pubmed: 10924499
Siragy, H. M., & Carey, R. M. (2010). Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. American Journal of Nephrology, 31(6), 541–550.
pubmed: 20484892
pmcid: 3202956
Urushihara, M., & Kagami, S. (2017). Role of the intrarenal renin–angiotensin system in the progression of renal disease. Pediatric Nephrology, 32(9), 1471–1479.
pubmed: 27380400
Wolf, G. (2004). New insights into the pathophysiology of diabetic nephropathy: From haemodynamics to molecular pathology. European Journal of Clinical Investigation, 34(12), 785–796.
pubmed: 15606719
Messaoudi, S., Azibani, F., Delcayre, C., & Jaisser, F. (2012). Aldosterone, mineralocorticoid receptor, and heart failure. Molecular and Cellular Endocrinology, 350(2), 266–272.
pubmed: 21784127
Jun, M., Jardine, M. J., Perkovic, V., Pilard, Q., Billot, L., Rodgers, A., et al. (2019). Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study. PLoS One, 14(3), e0213192.
Weir, M. R., Bakris, G. L., Gross, C., Mayo, M. R., Garza, D., Stasiv, Y., et al. (2016). Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors. Kidney International, 90(3), 696–704.
pubmed: 27350174
Vejakama, P., Ingsathit, A., McKay, G. J., Maxwell, A. P., McEvoy, M., Attia, J., et al. (2017). Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients. BMC Nephrology, 18(1), 342.
pubmed: 29187194
pmcid: 5706339
Abd Allah, E. S., & Gomaa, A. M. (2015). Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: Role of angiotensin converting enzyme 1. Applied Physiology, Nutrition, and Metabolism, 40(10), 1061–1067.
pubmed: 26398443
Dedkova, E. N. (2015). Some like it hot: Cardioprotective effect of curcumin in chronic kidney disease. Springer.
Xu, X., Cai, Y., & Yu, Y. (2018). Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats. Inflammopharmacology, 26(5), 1257–1264.
pubmed: 29582239
pmcid: 6153927
He, J., Xu, Y., Koya, D., & Kanasaki, K. (2013). Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clinical and Experimental Nephrology, 17(4), 488–497.
pubmed: 23430391
Zhao, H., Dong, Y., Tian, X., Tan, T. K., Liu, Z., Zhao, Y., et al. (2013). Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World Journal of Nephrology, 2(3), 84.
pubmed: 24255890
pmcid: 3832915
Johnson, T. S., Fisher, M., Haylor, J. L., Hau, Z., Skill, N. J., Jones, R., et al. (2007). Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. Journal of the American Society of Nephrology, 18(12), 3078–3088.
pubmed: 18003782
Zhang, Z.-H., Wei, F., Vaziri, N. D., Cheng, X.-L., Bai, X., Lin, R.-C., et al. (2015). Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Scientific Reports, 5, 14472.
Zhang, D., Huang, C., Yang, C., Liu, R. J., Wang, J., Niu, J., et al. (2011). Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respiratory Research, 12(1), 154.
pubmed: 22126332
pmcid: 3260240
Zhou, X., Zhang, J., Xu, C., & Wang, W. (2014). Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition. Journal of Pharmacological Sciences, 126(4), 344–350.
pubmed: 25452269
Saidi, A., Kasabova, M., Vanderlynden, L., Wartenberg, M., Kara-Ali, G. H., Marc, D., et al. (2019). Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L. Scientific Reports, 9(1), 1–15.
Smith, M. R., Gangireddy, S. R., Narala, V. R., Hogaboam, C. M., Standiford, T. J., Christensen, P. J., et al. (2010). Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology, 298(5), L616–L625.
pubmed: 20061443
pmcid: 2867399
Xu, S., Jiang, B., Wang, H., Shen, C., Chen, H., & Zeng, L. (2017). Curcumin suppresses intestinal fibrosis by inhibition of PPARγ-mediated epithelial-Mesenchymal transition. Evidence-Based Complementary and Alternative Medicine, 2017.
Rodriguez, L. R., Bui, S., Beuschel, R., Ellis, E., Liberti, E., Chhina, M., et al. (2019). Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis. Molecular Medicine, 25(1), 27.
pubmed: 31195971
pmcid: 6567541
Sun, X., Liu, Y., Li, C., Wang, X., Zhu, R., Liu, C., et al. (2017). Recent advances of curcumin in the prevention and treatment of renal fibrosis. BioMed Research International, 2017, 2418671.
Soetikno, V., Sari, F. R., Veeraveedu, P. T., Thandavarayan, R. A., Harima, M., Sukumaran, V., et al. (2011). Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutrition & Metabolism, 8(1), 35.
Zhong, F., Chen, H., Han, L., Jin, Y., & Wang, W. (2011). Curcumin attenuates lipopolysaccharide-induced renal inflammation. Biological and Pharmaceutical Bulletin, 34(2), 226–232.
pubmed: 21415532
Jones, E. A., Shahed, A., & Shoskes, D. A. (2000). Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology, 56(2), 346–351.
pubmed: 10925121
Gaedeke, J., Noble, N. A., & Border, W. A. (2005). Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. Kidney International, 68(5), 2042–2049.
pubmed: 16221204
Ghelani, H., Razmovski-Naumovski, V., Chang, D., & Nammi, S. (2019). Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats. BMC Nephrology, 20(1), 1–13.
Zheng, L., Li, Y., Li, X., Kou, J., Zhong, Z., Jiang, Y., et al. (2016). Combination of hydroxyl acetylated curcumin and ultrasound induces macrophage autophagy with anti-apoptotic and anti-lipid aggregation effects. Cellular Physiology and Biochemistry, 39(5), 1746–1760.
pubmed: 27744450
Molina-Jijón, E., Aparicio-Trejo, O. E., Rodríguez-Muñoz, R., León-Contreras, J. C., del Carmen, C.-A. M., Medina-Campos, O. N., et al. (2016). The nephroprotection exerted by curcumin in maleate-induced renal damage is associated with decreased mitochondrial fission and autophagy. Bio Factors, 42(6), 686–702.
Kim, B. H., Lee, E. S., Choi, R., Nawaboot, J., Lee, M. Y., Lee, E. Y., et al. (2016). Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Medical Journal, 57(3), 664–673.
pubmed: 26996567
pmcid: 4800357
Sampanis, C. (2008). Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure. Hippokratia, 12(1), 22.
pubmed: 18923754
pmcid: 2532962
Meng, B., Li, J., & Cao, H. (2013). Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Current Pharmaceutical Design, 19(11), 2101–2113.
pubmed: 23116316
Tabrizi, R., Vakili, S., Lankarani, K. B., Akbari, M., Mirhosseini, N., Ghayour-Mobarhan, M., et al. (2018). The effects of curcumin on glycemic control and lipid profiles among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Current Pharmaceutical Design, 24(27), 3184–3199.
pubmed: 30156145
L-q, S., & H-y, C. (2017). Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models. Saudi Journal of Biological Sciences, 24(8), 1776–1780.
Liu, N., Shi, Y., & Zhuang, S. (2016). Autophagy in chronic kidney diseases. Kidney Diseases, 2(1), 37–45.
pubmed: 27536690
pmcid: 4946255
Shakeri, A., Cicero, A. F., Panahi, Y., Mohajeri, M., & Sahebkar, A. (2019). Curcumin: A naturally occurring autophagy modulator. Journal of Cellular Physiology, 234(5), 5643–5654.
pubmed: 30239005
Liu, R., Zhang, H., Yang, J., Wang, J., Liu, J., & Li, C. (2018). Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR. European Review for Medical and Pharmacological Sciences, 22, 7500–7508.
Moreillon, J. J., Bowden, R. G., Deike, E., Griggs, J., Wilson, R., Shelmadine, B., et al. (2013). The use of an anti-inflammatory supplement in patients with chronic kidney disease. Journal of Complementary and Integrative Medicine, 10(1), 143–152.
Khajehdehi, P., Pakfetrat, M., Javidnia, K., Azad, F., Malekmakan, L., Nasab, M. H., et al. (2011). Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study. Scandinavian Journal of Urology and Nephrology, 45(5), 365–370.
pubmed: 21627399
Khajehdehi, P., Zanjaninejad, B., Aflaki, E., Nazarinia, M., Azad, F., Malekmakan, L., et al. (2012). Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study. Journal of Renal Nutrition, 22(1), 50–57.
pubmed: 21742514
Weir, M. A., Walsh, M., Cuerden, M. S., Sontrop, J. M., Chambers, L. C., & Garg, A. X. (2018). Micro-particle curcumin for the treatment of chronic kidney disease-1: Study protocol for a multicenter clinical trial. Canadian Journal of Kidney Health and Disease, 52054358118813088.
Shelmadine, B. D., Bowden, R. G., Moreillon, J. J., Cooke, M. B., Yang, P., Deike, E., et al. (2017). A pilot study to examine the effects of an anti-inflammatory supplement on eicosanoid derivatives in patients with chronic kidney disease. The Journal of Alternative and Complementary Medicine, 23(8), 632–638.
pubmed: 28375641
Jiménez-Osorio, A. S., García-Niño, W. R., González-Reyes, S., Álvarez-Mejía, A. E., Guerra-León, S., Salazar-Segovia, J., et al. (2016). The effect of dietary supplementation with curcumin on redox status and Nrf 2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: A pilot study. Journal of Renal Nutrition, 26(4), 237–244.
pubmed: 26915483